J. Scott Garland
CIK 1533228 · President and CEO · last filed 2026-06-05
J. Scott Garland is a President and CEO who has filed 43 SEC Form 4 insider transactions across 10 companies since 2011. The most recent filing, for LBRX, was dated Jun 5, 2026.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
10
43
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| LBRX | Director | — | $28.42 | — | $0 | 2 | 2026-06-05 |
| Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Director | — | $21.53 | — | $0 | 7 | 2026-04-23 |
| IMRA | Director | — | $17.02 | — | $0 | 2 | 2026-02-17 |
| ALXO | Director | — | $1.58 | — | $0 | 5 | 2026-01-21 |
| OLMA | Director | — | $9.87 | — | $0 | 3 | 2025-06-13 |
| CALA | Director | — | $0.00 | — | $0 | 3 | 2022-06-03 |
| PORTOLA PHARMACEUTICALS INC (PTLA) Delisted | President and CEO | 1,173 | — | — | $0 | 6 | 2020-07-02 |
| KPTI | Director | — | $9.50 | — | $0 | 6 | 2019-06-07 |
| Relypsa Inc (RLYP) Delisted | SVP & Chief Commercial Officer | 16,042 | — | — | $0 | 6 | 2016-09-02 |
| EXEL | EVP & Chief Commerical Officer | — | $53.13 | — | $0 | 3 | 2013-09-19 |
Recent Filings
43 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2026-06-05 | LBRX | Grant (A) | — | $0 | EDGAR |
| 2026-04-23 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Disp (D) | — | $0 | EDGAR |
| 2026-02-17 | IMRA | Grant (A) | — | $0 | EDGAR |
| 2026-01-21 | ALXO | Grant (A) | — | $0 | EDGAR |
| 2026-01-09 | IMRA | Grant (A) | — | $0 | EDGAR |
| 2025-11-07 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Mixed | — | $0 | EDGAR |
| 2025-09-12 | LBRX | Mixed | — | $0 | EDGAR |
| 2025-06-13 | OLMA | Grant (A) | — | $0 | EDGAR |
| 2025-06-04 | Day One Biopharmaceuticals, Inc. (DAWN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2025-01-23 | ALXO | Grant (A) | — | $0 | EDGAR |